SCHEMBL2834342

SCHEMBL2834342

NC(=O)c1cnn(-c2cccc(Cl)c2)c1N

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.70
HTT P42858 1/20 0.67
RAB9A P51151 4/20 0.64
LMNA P02545 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
NPC1 O15118 2/20 0.58
ATM Q13315 1/20 0.58
GAA P10253 2/20 0.52
MAPK14 Q16539 3/20 0.52
FGFR1 P11362 1/20 0.51
FGFR2 P21802 1/20 0.51
FGFR3 P22607 1/20 0.51
TSHR P16473 1/20 0.49
MAPT P10636 2/20 0.48
PARP1 P09874 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP3 Q9Y6F1 1/20 0.48
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3376392 0.88 HTT (0.67) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL15933265 0.87 HTT (0.69) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL8050439 0.87 RIPK2 (0.72) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL3427893 0.84 RIPK2 (0.68) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL3761319 0.84 RIPK2 (0.68) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL1691418 0.84 MAPK14 (0.72) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL15930131 0.83 HTT (0.65) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL2804588 0.83 RIPK2 (0.71) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL8050422 0.83 RIPK2 (0.71) RIPK2HTTRAB9ALMNASMN1; SMN2
SCHEMBL2743084 0.83 RIPK2 (1.00) RIPK2RAB9ALMNASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118367-A2 ANTIVIRAL PYRIMIDINES PROGENICS PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed